Newsbenzinga
NRx Pharmaceuticals Prices $20M Public Offering Of 5,714,286 Shares Of Common Stock At A Price Of $3.50/Share To Fund Working Capital And Growth Plans
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…